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unusual macular thickness in Alport syndrome: case report
Espessura macular atípica na síndrome de Alport: relato de caso
Thais Z. igami1, marcelo m. laveZZo2, Daniel a. FerraZ2, WalTer Y. Takahashi1, YoshiTaka nakashima2
INTRODUCTION
In 1927, Alport described the association of hereditary nephritis 
with sensorineural deafness observed in a family. In 1954, Sohar des­
cribed the presence of crystalline lens malformation associated with 
renal and hearing impairment. Finally, in 1961, Julien Marie reported 
the binding of Alport syndrome (AS) in the presence of anterior len­
ticonus(1).
As occurs in an approximate incidence of 1 for each 5,000 live 
births and their inheritance is linked to the X chromosome in 85% of 
cases, a reason why women still frequently develop disease although 
with less debilitating features since as lyonization offers females 
some protection(2,3). It consists of systemic changes due to mutation 
in the COL4A genes responsible for synthesis of α­chains of type 
IV collagen present in basement membranes of many tissues. The 
COL4A5 gene is associated with X­linked disease as long as COL4A3 
and COL4A4 genes occur mostly with autosomal recessive disease.
Among the tissues affected, some could be highlighted such as 
glomerular basement membrane, basement membrane of the organ 
of Corti of the cochlea, lens capsule and inner limi ting membrane as 
well as Bruch’s membrane in the eye(2,3). Gre gory et al., proposed that 
diagnosis of AS was confirmed by the presence of 4 of the 10 crite­
ria suggested by him(3). The main systemic presentations of Alport 
syndrome are: renal failure, sensorineural hearing loss and early low 
visual acuity, manifested in the second decade of life. The decline of 
renal function begins with persistent hematuria and proteinuria and 
culminates in glomerulosclerosis, leading to the need of kidney trans­
plant. The most common ocular changes are anterior lenticonus and 
retinal dots and flecks. Posterior lenticonus, posterior polymorphous 
dystrophy, macular hole and macular atrophy are less commonly 
reported(3­6).
CASE REPORT
A 48 year­old white female was conducted to the Ophthalmo­
logy Day Clinic with the diagnosis of Alport syndrome (AS) for in ­
ves tigation of chronic visual changes in both eyes (OU). The patient 
complained of bilateral low visual acuity (LVA) since childhood, which 
improved after phacoemulsification in both eyes. As personal and 
ocular history, she reported kidney transplant 24 years ago, bilateral 
progressive hearing loss 20 years ago and extracapsular crystalline 
extraction in OU, 23 years ago in the right eye (OD) and 33 years ago 
in the left eye (OS). She also had history of consanguineous marria ­
ge between her paternal grandparents. Her paternal grandfather, 
aunt and uncle experienced the triad: renal disease, deafness and 
low vision.
The ophthalmic exam demonstrated that best corrected visual 
acuity (BCVA) was 120/200 in OD and 140/200 in OS. Reflexes and 
external ocular motility were normal in OU. The slit lamp examination 
showed pseudophakia with posterior chamber intraocular lens (IOL) 
centered and without opacities in OU. At fundoscopy, there was 
symmetric, bilateral, discrete and circumscribed macular intense 
color of the retinal pigment epithelium (RPE) transmitted through 
RESUMO
Este relato de caso descreve a presença de atrofia macular bilateral em uma paciente com 
síndrome de Alport e compara este achado com a literatura. Ao exame fundoscópico, 
havia discreto afinamento macular circunscrito demonstrando a coloração intensa do 
epitélio pigmentado da retina e a presença de lesões retinianas circulares esbranquiçadas 
(“dots” e “flecks”) na média periferia nasal em ambos os olhos. A tomografia de coerência 
óptica identificou atrofia parcial da retina neurossensorial bilateral na mácula, com 
maior extensão na área temporal. O caso descreve uma alteração oftalmológica rara 
da síndrome de Alport e de importante reconhecimento para precisar o diagnóstico e 
também para determinar o prognóstico visual. 
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ABSTRACT
This case report describes the presence of bilateral macular atrophy in a patient with 
Alport syndrome and compares this finding with literature. At fundoscopy, there was a 
discrete circumscribed macular thinning showing intense retinal pigment epithelium 
color and the presence of whitish circular retinal lesions (“dots” and “flecks”) at nasal mid 
periphery of both eyes. Optical coherence tomography showed bilateral partial atrophy 
of the neurosensory retina in the macula, with a greater extent in the temporal region. 
This case describes a rare ophthalmological finding in Alport syndrome and important 
to be recognized for a precise diagnosis as well as for determining visual prognosis. 
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the thinned retina, comparable to a macular pseudohole. In the na­
sal mid­periphery, there were confluent ivory colored dots and flecks, 
apparently occupying intermediate levels of the retina in OU (Figure 1).
Fluorescein angiography revealed early hyperfluorescence in 
the well­defined macular region, which did not vary in intensity on 
late stages in OU. Optical coherence tomography (OCT) identified 
macular area with partial atrophy of neurosensory retina in OU, with 
a greater extent in the temporal region of the macula (Figure 1). The 
average foveal thickness was 112 µm in OD and 99 µm in the OS.
DISCUSSION
Ophthalmic signs in patients with AS include corneal endothe­
lium, retinal and crystalline lens abnormalities. LVA is consequent to 
modifications in the crystalline lens as anterior lenticonus, posterior 
lenticonus, microspherophakia and cataract and may be reversible 
after phacoemulsification and IOL implantation in the capsular bag(4). 
The most common retinal abnormality is a presence of peripheral and 
macular “dots” and “flecks”. These findings do not occur concomitantly 
with the BCVA decline(4,5). Other fundoscopic sings reported more 
rarely were: bilateral macular hole, vitelliform lesion and macular 
atrophy(5­9). The latter was first described by Usui et al.(7), and by other 
authors (Table 1). Recently, Savige et al., evaluated a case series of 
patients with AS and macular changes and found similar alterations 
to the described case(8). The authors suggest that mutation of COLA4 
gene causes a structural modification in the internal limiting mem­
brane, inner nuclear and nerve fiber layer due to owing to a molecular 
alteration of type IV collagen. This change would cause a thinning 
and fragility of retinal layers resulting from the structural collagen 
changeover. The thinning was statistically significant at the foveal and 
temporal region of macula(8). Colville et al., described the same macu­
lar alteration named as “lozenge” or “dull macular reflex” in a group of 
patients with AS, and highlighted the importance of acknowledging 
the findings with the aid of red­free image and its correlation with 
diagnosis and poor prognosis of the disease(10).
In the presented case, the patient was already pseudophakic and 
presented similar best­corrected visual acuity y (BCVA) in BE. Thus, 
there was no interference of the crystalline lens changes that could 
Table 1. Characteristics of patients affected by Alport syndrome in the presence of bilateral macular atrophy
Author/year
Number of patients 
described
OD/OS
BCVA
OD/OS 
MT (µm) Age (years) Gender
Usui/2004(7) 01 20/20
20/20
177/186 38 M
Colville/2009(9) 06 NI NI 11­41 M
Fawzi/2009(5) 01 20/40
20/50
NI 19 M
Savige/2010(8) 010 NI 214 ± 46  
(foveal)
14­74 7M 
3F
BCVA= best corrected visual acuity; MT= macular thickness; OD= right eye; OS= left eye; NI= not informed by the author; M= male; f= female
Figure 1. Changes observed in the right eye. A) Presence of circumscribed pigmentary change in the macula. B) Presence of “dots” and 
“flecks” in the nasal retina. C, D) OCT identified macular area with partial atrophy of neurosensory retina, with greater extent in the temporal 
region of macula. The average foveal thickness was 112 µm.
A
C
B
D
Igami TZ, et al.
285Arq Bras Oftalmol. 2012;75(4):283-5
justify the reduction of BCVA. Partial atrophy in the macular region 
while preserving the layer of photoreceptors could justify the relative 
interference on the visual potential. If her anterior lenticonus had 
been significant during early childhood, it is possible there could 
have been a slight degree of amblyopia contributing to poor vision. 
But probably, the lenticonus was not severe during childhood simply 
for the fact that renal failure requiring transplantation happened in 
her early adulthood (20 years old). 
This patient could not have electrophysiology or visual field stu dies. 
There are evidences that electrophysiological analysis of patients with 
Alport syndrome shows no additional information that could con tri­
bute on diagnosis or prognosis of this disease, since as renal disease 
alone can affect the results of electroretinogram (ERG)(10). 
Histopathological studies of retina that provide detailed informa­
tion are needed for possible increments in gene therapy as alternati­
ve treatment of patients with AS
The case describes the presence of bilateral macular atrophy in 
AS, a rare ocular finding that is important to be recognized for the 
correct diagnosis of the disease as well as to transmit a visual progno­
sis to the patient before or after cataract surgery. There are evidences 
that this kind of maculopathy can impair visual acuity (Table 1).
The finding of retinal changes related to Alport syndrome can 
also estimate the risk for renal bankruptcy(9).
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